Newsroom

SOUTH BURLINGTON, Vt.--(BUSINESS WIRE)--BETA Technologies, Inc. (NYSE: BETA) (“BETA” or the “Company”), an electric aerospace company, today announced its financial and operating results for the first quarter ended March 31, 2026. “Since the beginning of the year, BETA has made critical progress in support of our stepwise approach to electrify aviation, demonstrating our leadership position in the advanced air mobility sector as we prepare to enter eIPP operations,” said Kyle Clark, President a...

LAS VEGAS--(BUSINESS WIRE)--Skillz Inc. (NYSE: SKLZ) (“Skillz” or the “Company”), the leading competitive mobile gaming platform bringing fair and fun competition to players worldwide, today announced that it will release its 2026 first quarter financial results after the market closes on Friday, May 15, 2026 and host a conference call and webcast on Tuesday, May 19, 2026 at 4:30 p.m. ET. During the call, Skillz management will review the Company’s financial results and provide a business updat...

AMSTERDAM--(BUSINESS WIRE)--Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”) and KDDI Corporation (TYO: 9433) (“KDDI”) today announced they have entered into an agreement (the “Subscription Agreement”) pursuant to which KDDI, a telecommunications company with one of the largest customer bases in Japan, will invest in Coincheck Group, a Dutch public limited liability company that provides digital asset trade execution, custody, staking and asset management services. Concu...

PORTLAND, Ore.--(BUSINESS WIRE)--Payfinia, an independent payment services firm providing an open framework, today announced the appointment of Keith Riddle as Chief Executive Officer. Building on strong company momentum, expanded adoption of its Instant Payments Xchange™ (IPX) platform and continued ecosystem expansion, Riddle will be instrumental in leading its next phase of growth. “As a founding investor and co-founder of the Payfinia CUSO, Star One backed this platform to put real-time pay...

AMSTERDAM--(BUSINESS WIRE)--Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”), a Dutch public limited liability company that provides digital asset trade execution, custody, staking and asset management services, today reported financial results for the fourth quarter of the fiscal year ended March 31, 2026 (“fiscal 2026”). References to “fiscal 2025” mean the fiscal year ended March 31, 2025. Financial Highlights:1 Certain Year-Over-Year Highlights Total revenue for the...

WASHINGTON--(BUSINESS WIRE)--Global Relay, a leading provider of digital communications governance and archiving solutions for global financial services and other highly regulated industries, today announced its presence at the 2026 FINRA Annual Conference with a dedicated Surveillance Command Center — an immersive showcase designed for compliance leaders to experience firsthand how AI-enabled communications monitoring is redefining the standard for surveillance in financial services. Global Re...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter...

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Kennedy-Wilson, Inc. (the “Issuer”), a wholly-owned subsidiary of global real estate investment company Kennedy-Wilson Holdings, Inc. (the “Company” or “Kennedy Wilson”), today announced that it has commenced a private offering (the “Offering”) of $1.8 billion in aggregate principal amount of senior notes, consisting of senior notes due 2031 (the “2031 Notes”) and senior notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) purs...

NEW YORK--(BUSINESS WIRE)--Forus, the company accelerating medicine for the people who need it, prescribe it, and create it, today announced it has raised over $160M. Formerly known as Tandem, the company is backed by Thrive Capital, General Catalyst, Accel, Bain Capital Ventures (BCV), Redpoint, BoxGroup, and Pear VC. Scientific progress in medicine is accelerating, but getting breakthroughs to patients remains slow and unreliable. Bringing a new drug to market takes 10 to 15 years and costs $...

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, announces its financial results for the quarter ended March 31, 2026 and provides a corporate update. “We are off to a strong start in 2026, building on the clinical and scientific progress achieved last year,” said Arun Swaminathan, Ph.D., Chief Executive O...